BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 177 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $566,000 | -58.8% | 3,881 | -66.5% | 0.00% | 0.0% |
| Q1 2022 | $1,373,000 | -58.5% | 11,580 | -70.0% | 0.00% | -83.3% |
| Q4 2020 | $3,307,000 | +369.7% | 38,581 | +256.3% | 0.01% | +200.0% |
| Q3 2020 | $704,000 | +4.9% | 10,829 | +18.0% | 0.00% | -33.3% |
| Q2 2020 | $671,000 | +57.5% | 9,180 | -26.7% | 0.00% | 0.0% |
| Q1 2020 | $426,000 | -85.6% | 12,529 | -77.0% | 0.00% | -85.0% |
| Q4 2019 | $2,967,000 | -19.6% | 54,504 | -38.4% | 0.02% | -33.3% |
| Q3 2019 | $3,689,000 | -18.1% | 88,421 | -14.0% | 0.03% | -26.8% |
| Q2 2019 | $4,504,000 | +6937.5% | 102,847 | +5942.7% | 0.04% | +4000.0% |
| Q3 2018 | $64,000 | -67.0% | 1,702 | -65.3% | 0.00% | -50.0% |
| Q2 2018 | $194,000 | -88.7% | 4,904 | -92.6% | 0.00% | -88.2% |
| Q1 2018 | $1,713,000 | – | 66,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $108,659,000 | 54.35% |
| Knoll Capital Management, LLC | 749,815 | $38,593,000 | 29.33% |
| VHCP Management II, LLC | 1,138,075 | $58,577,000 | 17.14% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,021,392 | $52,571,000 | 11.19% |
| Aisling Capital Management LP | 274,513 | $14,129,000 | 10.76% |
| Foresite Capital Management IV, LLC | 518,560 | $26,690,000 | 9.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 844,266 | $43,454,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 206,000 | $10,603,000 | 5.04% |
| ARS Investment Partners, LLC | 464,127 | $23,889,000 | 4.32% |
| Cormorant Asset Management, LP | 1,100,000 | $56,617,000 | 3.83% |